CD70 and ovarian carcinoma: Notably, a few Phase I trials (e.g., NCT05518253, NCT06215950, NCT05420545, NCT05468190) are investigating the safety and efficacy of CD70 CAR T-cells in advanced/metastatic solid tumors, including epithelial ovarian cancer.